Cargando…
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Non-tumoural cells within the tumour microenvironment (TME) influence tumour proliferation, invasiveness and angiogenesis. Little is known about TME in pituitary neuroendocrine tumours (PitNETs). We aimed to characterise the role of TME in the aggressive behaviour of PitNETs, focusing on immune cell...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839241/ https://www.ncbi.nlm.nih.gov/pubmed/31703742 http://dx.doi.org/10.1186/s40478-019-0830-3 |
_version_ | 1783467376662020096 |
---|---|
author | Marques, Pedro Barry, Sayka Carlsen, Eivind Collier, David Ronaldson, Amy Awad, Sherine Dorward, Neil Grieve, Joan Mendoza, Nigel Muquit, Samiul Grossman, Ashley B. Balkwill, Frances Korbonits, Márta |
author_facet | Marques, Pedro Barry, Sayka Carlsen, Eivind Collier, David Ronaldson, Amy Awad, Sherine Dorward, Neil Grieve, Joan Mendoza, Nigel Muquit, Samiul Grossman, Ashley B. Balkwill, Frances Korbonits, Márta |
author_sort | Marques, Pedro |
collection | PubMed |
description | Non-tumoural cells within the tumour microenvironment (TME) influence tumour proliferation, invasiveness and angiogenesis. Little is known about TME in pituitary neuroendocrine tumours (PitNETs). We aimed to characterise the role of TME in the aggressive behaviour of PitNETs, focusing on immune cells and cytokines. The cytokine secretome of 16 clinically non-functioning PitNETs (NF-PitNETs) and 8 somatotropinomas was assessed in primary culture using an immunoassay panel with 42 cytokines. This was correlated with macrophage (CD68, HLA-DR, CD163), T-lymphocyte (CD8, CD4, FOXP3), B-lymphocyte (CD20), neutrophil (neutrophil elastase) and endothelial cells (CD31) content, compared to normal pituitaries (NPs, n = 5). In vitro tumour–macrophage interactions were assessed by conditioned medium (CM) of GH3 (pituitary tumour) and RAW264.7 (macrophage) cell lines on morphology, migration/invasion, epithelial-to-mesenchymal transition and cytokine secretion. IL-8, CCL2, CCL3, CCL4, CXCL10, CCL22 and CXCL1 are the main PitNET-derived cytokines. PitNETs with increased macrophage and neutrophil content had higher IL-8, CCL2, CCL3, CCL4 and CXCL1 levels. CD8+ T-lymphocytes were associated to higher CCL2, CCL4 and VEGF-A levels. PitNETs had more macrophages than NPs (p < 0.001), with a 3-fold increased CD163:HLA-DR macrophage ratio. PitNETs contained more CD4+ T-lymphocytes (p = 0.005), but fewer neutrophils (p = 0.047) with a 2-fold decreased CD8:CD4 ratio. NF-PitNETs secreted more cytokines and had 9 times more neutrophils than somatotropinomas (p = 0.002). PitNETs with higher Ki-67 had more FOXP3+ T cells, as well as lower CD68:FOXP3, CD8:CD4 and CD8:FOXP3 ratios. PitNETs with “deleterious immune phenotype” (CD68(hi)CD4(hi)FOXP3(hi)CD20(hi)) had a Ki-67 ≥ 3%. CD163:HLA-DR macrophage ratio was positively correlated with microvessel density (p = 0.015) and area (p < 0.001). GH3 cell-CM increased macrophage chemotaxis, while macrophage-CM changed morphology, invasion, epithelial-to-mesenchymal transition and secreted cytokines of GH3 cells. PitNETs are characterised by increased CD163:HLA-DR macrophage and reduced CD8:CD4 and CD8:FOXP3 T cell ratios. PitNET-derived chemokines facilitate macrophage, neutrophil and T cell recruitment into the tumours which can determine aggressive behaviour. |
format | Online Article Text |
id | pubmed-6839241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68392412019-11-12 Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours Marques, Pedro Barry, Sayka Carlsen, Eivind Collier, David Ronaldson, Amy Awad, Sherine Dorward, Neil Grieve, Joan Mendoza, Nigel Muquit, Samiul Grossman, Ashley B. Balkwill, Frances Korbonits, Márta Acta Neuropathol Commun Research Non-tumoural cells within the tumour microenvironment (TME) influence tumour proliferation, invasiveness and angiogenesis. Little is known about TME in pituitary neuroendocrine tumours (PitNETs). We aimed to characterise the role of TME in the aggressive behaviour of PitNETs, focusing on immune cells and cytokines. The cytokine secretome of 16 clinically non-functioning PitNETs (NF-PitNETs) and 8 somatotropinomas was assessed in primary culture using an immunoassay panel with 42 cytokines. This was correlated with macrophage (CD68, HLA-DR, CD163), T-lymphocyte (CD8, CD4, FOXP3), B-lymphocyte (CD20), neutrophil (neutrophil elastase) and endothelial cells (CD31) content, compared to normal pituitaries (NPs, n = 5). In vitro tumour–macrophage interactions were assessed by conditioned medium (CM) of GH3 (pituitary tumour) and RAW264.7 (macrophage) cell lines on morphology, migration/invasion, epithelial-to-mesenchymal transition and cytokine secretion. IL-8, CCL2, CCL3, CCL4, CXCL10, CCL22 and CXCL1 are the main PitNET-derived cytokines. PitNETs with increased macrophage and neutrophil content had higher IL-8, CCL2, CCL3, CCL4 and CXCL1 levels. CD8+ T-lymphocytes were associated to higher CCL2, CCL4 and VEGF-A levels. PitNETs had more macrophages than NPs (p < 0.001), with a 3-fold increased CD163:HLA-DR macrophage ratio. PitNETs contained more CD4+ T-lymphocytes (p = 0.005), but fewer neutrophils (p = 0.047) with a 2-fold decreased CD8:CD4 ratio. NF-PitNETs secreted more cytokines and had 9 times more neutrophils than somatotropinomas (p = 0.002). PitNETs with higher Ki-67 had more FOXP3+ T cells, as well as lower CD68:FOXP3, CD8:CD4 and CD8:FOXP3 ratios. PitNETs with “deleterious immune phenotype” (CD68(hi)CD4(hi)FOXP3(hi)CD20(hi)) had a Ki-67 ≥ 3%. CD163:HLA-DR macrophage ratio was positively correlated with microvessel density (p = 0.015) and area (p < 0.001). GH3 cell-CM increased macrophage chemotaxis, while macrophage-CM changed morphology, invasion, epithelial-to-mesenchymal transition and secreted cytokines of GH3 cells. PitNETs are characterised by increased CD163:HLA-DR macrophage and reduced CD8:CD4 and CD8:FOXP3 T cell ratios. PitNET-derived chemokines facilitate macrophage, neutrophil and T cell recruitment into the tumours which can determine aggressive behaviour. BioMed Central 2019-11-08 /pmc/articles/PMC6839241/ /pubmed/31703742 http://dx.doi.org/10.1186/s40478-019-0830-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Marques, Pedro Barry, Sayka Carlsen, Eivind Collier, David Ronaldson, Amy Awad, Sherine Dorward, Neil Grieve, Joan Mendoza, Nigel Muquit, Samiul Grossman, Ashley B. Balkwill, Frances Korbonits, Márta Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title | Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title_full | Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title_fullStr | Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title_full_unstemmed | Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title_short | Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
title_sort | chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839241/ https://www.ncbi.nlm.nih.gov/pubmed/31703742 http://dx.doi.org/10.1186/s40478-019-0830-3 |
work_keys_str_mv | AT marquespedro chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT barrysayka chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT carlseneivind chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT collierdavid chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT ronaldsonamy chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT awadsherine chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT dorwardneil chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT grievejoan chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT mendozanigel chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT muquitsamiul chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT grossmanashleyb chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT balkwillfrances chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours AT korbonitsmarta chemokinesmodulatethetumourmicroenvironmentinpituitaryneuroendocrinetumours |